Trade CTKB anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Cytek Biosciences, Inc. (CTKB) is trading at US$4.61, down 0.32% today as of Aug 28, 13:07 EDT. The company has a market capitalisation of US$625.22M. Over the past 52 weeks, CTKB has traded between US$3.28 and US$6.18. On Syfe you can trade CTKB with $0 commission and add it to your watchlist.
| Previous close | US$4.62 |
|---|---|
| Market cap | US$625.22M |
| 52-week range | US$3.28 – US$6.18 |
| Volume | 651.35K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cytek Biosciences, Inc.
Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC. The company was founded by Wenbin Jiang and Ming Yan in 1992 and is headquartered in Fremont, CA.
Year: 2021
Cytek Biosciences Opens Innovation Center in Washington
Jul 15, 9:23 PM · MT Newswires
Cytek Biosciences Removes Chief Legal Officer
Jun 26, 9:59 AM · MT Newswires
--Morgan Stanley Cuts Price Target on Cytek Biosciences to $5.50 From $6, Keeps Equalweight Rating
May 12, 10:42 AM · MT Newswires
Cytek Biosciences, Inc. (CTKB) stock is trading at US$4.61, -0.32% from the previous close of US$4.62.
The market cap for Cytek Biosciences, Inc. (CTKB) stock is approximately US$625.22M.
The 52-week high for Cytek Biosciences, Inc. (CTKB) stock is US$6.18.
The 52-week low for Cytek Biosciences, Inc. (CTKB) stock is US$3.28.
Cytek Biosciences, Inc. (CTKB) does not currently pay a dividend.
Stay on top of CTKB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
